Assessment of ventilation heterogeneity in severe asthma using phase‐resolved functional lung magnetic resonance imaging
Physiological Reports · 2025
DOI: 10.14814/phy2.70423 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physiological Reports, 2025. Verfasst von Chuan T Foo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Asthma, Magnetic Resonance Imaging, Lung, Pulmonary Ventilation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Health | National Health and Medical Research Council (NHMRC), MU | Faculty of Medicine, Nursing and Health Sciences, Monash University, National Health and Medical Research Council.
Abstract (Originalsprache)
Ventilation heterogeneity is a hallmark of asthma. This study examines the feasibility of phase‐resolved functional lung magnetic resonance imaging (PREFUL MRI) in the evaluation of ventilation heterogeneity in severe asthma, its response to bronchodilator, and correlation with spirometry. Twenty‐three patients with severe asthma and seven healthy volunteers completed PREFUL MRI and spirometry pre and post‐bronchodilator. Ventilation heterogeneity was assessed using ventilation defect percentages (VDP) for regional ventilation (RVent) and flow‐volume loop cross‐correlation (FVL), interquartile distance (IQD), and inhomogeneity index (IHI). Patients exhibited a significantly higher pre‐bronchodilator VDP RVent (19.9 ± 14.0 vs. 1.9 ± 1.9%, p < 0.001), VDP FVL (21.6 ± 15.9 vs. 1.7 ± 2.1%, p < 0.001), IQD (0.60 ± 0.25 vs. 0.30 ± 0.06, p < 0.001), and IHI (0.34 ± 0.12 vs. 0.18 ± 0.04, p < 0.001) compared to healthy volunteers. Post‐bronchodilator, VDP RVent (14.7 ± 12.5 vs. 19.9 ± 14.0%, p = 0.02), IQD (0.51 ± 0.20 vs. 0.60 ± 0.25, p = 0.02), and IHI (0.30 ± 0.11 vs. 0.34 ± 0.12, p = 0.02) decreased significantly in patients but remained significantly higher than in healthy volunteers. Significant correlations were observed between pre‐bronchodilator FEV1 and VDP RVent ( ρ = −0.61, p < 0.001), VDP FVL ( ρ = −0.73, p < 0.001), IQD ( ρ = −0.57, p =
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia.
- Department of Respiratory Medicine, Eastern Health, Melbourne, Victoria, Australia.
- Department of Thoracic Medicine, Peninsula Health, Frankston, Victoria, Australia.
- Department of Mathematics, University of Auckland, Auckland, New Zealand.
- School of Health Sciences, University of Melbourne, Melbourne, Victoria, Australia.
- School of Human Sciences, The University of Western Australia, Perth, Western Australia, Australia.
ORCID-Profile: Chuan T Foo
Förderung
- Department of Health | National Health and Medical Research Council (NHMRC)
- MU | Faculty of Medicine, Nursing and Health Sciences, Monash University
- National Health and Medical Research Council
- Faculty of Medicine, Nursing and Health Sciences, Monash University
Zitieren
APA
Foo, C. T., Langton, D., Donovan, G. M., Thompson, B. R., Noble, P. B., & Thien, F. (2025). Assessment of ventilation heterogeneity in severe asthma using phase‐resolved functional lung magnetic resonance imaging. Physiological Reports. https://doi.org/10.14814/phy2.70423
Vancouver
Foo CT, Langton D, Donovan GM, Thompson BR, Noble PB, Thien F. Assessment of ventilation heterogeneity in severe asthma using phase‐resolved functional lung magnetic resonance imaging. Physiological Reports. 2025. doi:10.14814/phy2.70423
BibTeX
@article{Foo2025,
author = {Foo, Chuan T and Langton, David and Donovan, Graham M and Thompson, Bruce R and Noble, Peter B and Thien, Francis},
title = {Assessment of ventilation heterogeneity in severe asthma using phase‐resolved functional lung magnetic resonance imaging},
journal = {Physiological Reports},
year = {2025},
doi = {10.14814/phy2.70423}
}
EUVIMED